3-O-Methylfunicone

From WikiMD's WELLNESSPEDIA


Chemical structure of 3-O-Methylfunicone

3-O-Methylfunicone is a secondary metabolite produced by certain fungi. It belongs to the class of compounds known as polyketides, which are synthesized by the polyketide synthase enzyme complex. This compound has attracted interest due to its potential biological activity and pharmacological properties.

Chemical Structure[edit]

3-O-Methylfunicone is characterized by its unique chemical structure, which includes a lactone ring and several hydroxyl groups. The presence of a methoxy group at the third position of the funicone backbone distinguishes it from other related compounds. The chemical structure can be represented by the molecular formula C15H18O5.

Biosynthesis[edit]

The biosynthesis of 3-O-Methylfunicone involves the polyketide pathway, a complex process that assembles the compound from simple acetate units. This pathway is catalyzed by a series of enzymes that include ketosynthase, acyltransferase, and dehydratase domains. The final steps involve the modification of the polyketide chain to form the characteristic lactone ring and the addition of the methoxy group.

Biological Activity[edit]

3-O-Methylfunicone has been studied for its potential antimicrobial and antitumor activities. It has shown inhibitory effects against certain bacterial and fungal species, making it a candidate for the development of new antibiotics. Additionally, preliminary studies suggest that it may have cytotoxic effects on certain cancer cell lines, although further research is needed to fully understand its mechanism of action.

Applications[edit]

Due to its biological activities, 3-O-Methylfunicone is of interest in the field of drug discovery. Researchers are exploring its potential as a lead compound for the development of new therapeutic agents. Its unique structure also makes it a subject of study in organic chemistry for the synthesis of novel analogs with enhanced properties.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.